<--- Back to Details
First PageDocument Content
Gene delivery / Vaccination / Molecular biology / DNA vaccination / Vaccine / Influenza vaccine / Plasmid / Antigen / Virus / Biology / Immune system / Microbiology
Date: 2010-02-12 15:16:27
Gene delivery
Vaccination
Molecular biology
DNA vaccination
Vaccine
Influenza vaccine
Plasmid
Antigen
Virus
Biology
Immune system
Microbiology

The Clinical Newsletter DNAVaccines - A viable alternative.January 2010.pub

Add to Reading List

Source URL: www.garretthealth.org

Download Document from Source Website

File Size: 31,89 KB

Share Document on Facebook

Similar Documents

Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. Founded 1999, Clague Hodgson, Ph.D. Chief Scientific Officer, VP, R&D, Jim Williams, Ph.D. (200

DocID: 1uuzW - View Document

Biology / Molecular biology / Biochemistry / Chemistry / Gene delivery / DNA / Boehringer Ingelheim / DNA vaccination / Plasmid / Boehringer / Agarose gel electrophoresis / Alkaline lysis

Microsoft PowerPoint - Flyer pDNA

DocID: 1qqYL - View Document

Medicine / Microbiology / Clinical medicine / Ebola / Vaccines / Vaccination / Animal virology / Biological weapons / Ebola virus / DNA vaccination / Immunogenicity / Virus

Microsoft Word - jiu511.doc

DocID: 1qpVj - View Document

Zoonoses / Biological weapons / Tropical diseases / Animal virology / Ebola / Ebola virus / Marburg virus disease / Vaccine / DNA vaccination / Virus / Marburg virus / Vaccinia

SUPPLEMENT ARTICLE Kunjin Virus Replicon-Based Vaccines Expressing Ebola Virus Glycoprotein GP Protect the Guinea Pig Against Lethal Ebola Virus Infection

DocID: 1pCnO - View Document

Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. • Founded 1999, Clague Hodgson, Ph.D. • Chief Scientific Officer, VP, R&D, Jim Williams, Ph

DocID: 1jJjX - View Document